Windtree Therapeutics Inc
WINT· OTC
Filed Mar 15, 2013 · 10-K · 74 days after period end · 0001140361-13-012728
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Net Income | -$6.82M | -$4.30M | — |
| EPS Diluted | -$0.16 | -$0.18 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Windtree Therapeutics Inc · CIK 946486 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 15, 2013 · 74 d after period end